SH2B3 helps keep immune and blood-forming cells from overreacting to growth signals. This gene plays an important role in balancing inflammation and how many blood cells your bone marrow makes. When the SH2B3 gene does not work well, signaling can run too “hot,” which may contribute to high blood counts, clotting problems, or immune-related illness. Some SH2B3 variants are linked to a higher chance of certain blood cancers and autoimmune conditions, but they influence risk rather than determining outcomes.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or guide what happens in the body. Many genes provide the code for proteins, which act as the cell’s main working components. Some genes are used more for regulation, helping set the timing, location, and intensity of certain body activities. As a whole, genes affect how your body grows and works, and they can influence how you react to food, stress, or medicines. To go deeper into this topic, you can find more information in the LearnHub.
Overview
SH2B3Gene function
What if the gene works
SH2B3 helps keep immune and blood-forming cells from overreacting to growth signals. By putting a brake on these signals, the SH2B3 gene supports balanced blood cell production and immune responses.
Risk
What if the gene does not work
Changes in the SH2B3 gene that reduce its function can leave immune and blood cell signals less controlled, leading to high blood counts and, in some cases, myeloproliferative neoplasms. Effects can range from mild to severe depending on the variant.
Treatment
What does that mean for your treatment
Some variants in the SH2B3 gene can boost JAK signaling, so treatment may favor medicines that dampen this pathway, such as JAK inhibitors, when appropriate. SH2B3 results do not change drug choice alone, but can add context with other findings.
Conditions associated with SH2B3
Gene function
What if the gene works
Day to day, your bone marrow and immune system rely on steady messaging to decide when to make new blood cells and when to activate defenses. The SH2B3 gene helps fine-tune those messages, acting like a built-in volume control. When it works properly, cell signals stay proportionate and blood cell production remains well regulated.
The SH2B3 gene helps certain cells put the brakes on growth messages coming from chemical signals in the blood. This keeps cell-to-cell communication steady so tissues respond without overshooting.
In bone marrow, SH2B3 supports balanced production of red cells, white cells, and platelets by tempering strong make more signals. This everyday control is central to the SH2B3 gene’s role in immune system signaling and blood formation.
This gene helps immune cells respond to infections in a measured way by dialing back signals once they have been received. It supports a balanced inflammatory response so routine immune activity stays proportionate.
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences are widespread and are part of normal human variation, including traits like appearance, metabolism, and how the body reacts to environmental factors. Many variants do not cause any noticeable changes and are simply a normal part of genetic diversity. In certain situations, though, a variant can affect how a gene works more significantly and may help lead to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SH2B3 gene can reduce an internal “brake” on immune and bone marrow signals, which may nudge the body toward inflammation or higher blood cell production. Many SH2B3 gene variants are mild and mainly shift the chance of issues such as autoimmunity or clotting without guaranteeing them. Rarer, more disruptive SH2B3 mutations can have a stronger effect and may be linked to earlier onset or more noticeable findings, including unusual blood counts. This range helps explain why SH2B3 gene variants linked to autoimmune disease and high platelet counts can look very different from person to person.
How variants are linked to conditions
Studies have found SH2B3 gene variants linked to autoimmune disease risk, including celiac disease, type 1 diabetes, and rheumatoid arthritis. In population studies, changes near the SH2B3 gene are also associated with differences in blood cell counts and a higher risk of certain blood cancers such as myeloproliferative neoplasms, as well as modest shifts in risk for high blood pressure and coronary artery disease. For common variants, these associations influence risk rather than guaranteeing any diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a typical feature of human biology and occur frequently across the population. In most situations, these variants do not directly affect health and instead represent normal differences among people. For a wide range of genes, having a variant that is associated with a condition points to a potential link rather than a certain diagnosis, particularly when many genes and environmental influences contribute. Still, there are situations where one clearly understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes in the SH2B3 gene usually shift risk rather than determine whether you will get a condition, and your overall risk is also shaped by other genes, family history, age, and sex. For problems linked with SH2B3, such as some immune and heart-and-blood-vessel conditions, smoking, high blood pressure, high cholesterol, and excess weight can raise overall risk. There is not enough evidence to say lifestyle changes specifically “cancel out” SH2B3-related risk, but healthy habits still matter for prevention and early detection.
Inheritance of SH2B3 variants
Changes in the SH2B3 gene are usually inherited in an autosomal dominant pattern, meaning one changed copy can be passed on and may influence health depending on the specific variant. This inheritance of SH2B3 gene variants can come from either parent, and each child has a 50% chance of inheriting the same change. Sometimes the change happens for the first time in a person (de novo) rather than being inherited.
What does my SH2B3 result mean for my family?
If your SH2B3 result is linked to a blood or immune condition in your family, get medical advice when you notice unusual clotting or bleeding, repeated infections, ongoing fevers, unexplained tiredness, or new easy bruising. A SH2B3 result can also matter before pregnancy, surgery, or starting medicines that affect the immune system or blood clotting, because care plans may need adjusting. Seek urgent care for chest pain, sudden shortness of breath, one-sided weakness, or coughing up blood.
Genetic information
Genetic testing
How you find out about variants
A SH2B3 gene test looks for changes in your DNA that may be linked to certain health risks or blood count findings. Testing usually uses a blood draw or saliva sample, and a lab reads the SH2B3 gene using DNA sequencing, then compares your results with a standard reference. The report lists detected variants and how well they are understood.
When should I consider getting a genetic test?
Consider SH2B3 genetic testing if you or close relatives have long-lasting unusual blood counts (very high platelets or red cells), unexplained blood clots, or a blood cancer where the body makes too many blood cells at a young age. It can also help when repeated blood tests stay abnormal and other common causes have been ruled out.
A genetic result is only one part of your health story
A genetic test result can be very informative, but what it can tell you varies based on the condition and the specific kind of variant found. How your body functions over time is also shaped by factors like lifestyle, environment, age, and your medical history. With some conditions, particularly those affected by many genes, genetic findings provide helpful background rather than a definite prediction and make the most sense when considered with other parts of your care. In other situations, genetic information can offer a straightforward conclusion. For topics like how you respond to medications, these results can also help put your personal experience in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic differences can affect how people respond to medicines, and most genes do not have a clear, clinically used role in guiding medication choice. The SH2B3 gene mainly supports immune and blood cell signaling, and it is not a standard pharmacogenetic marker for predicting how your body breaks down drugs or which dose you need. Even so, common genetic variation across the body can change how quickly a medication is processed, how strongly it works at its target, or how sensitive you are to side effects. This helps explain why the same treatment can feel very effective for one person yet less helpful or less well tolerated for another.
What is Pharmacogenetics?
Pharmacogenetics focuses on how inherited genetic differences can shape the way a person responds to medications. It examines relationships between genes and specific drugs to explain why the same treatment can have different effects in different people. For many medicines, your genes can affect how powerfully a drug works or how your body breaks it down. Understanding these patterns can support treatment choices that are more informed and tailored to the individual. More information on this topic is available in the LearnHub.
Drugs influenced by the SH2B3 gene
When should I seek medical advice?
Seek medical advice if you have unusual bruising or bleeding, frequent infections, lasting fatigue, joint swelling, or blood tests showing abnormal blood counts. If you know you carry a change in the SH2B3 gene, share this before starting or changing medicines that affect the immune system or blood. Get urgent care for chest pain or trouble breathing.
History
The SH2B3 gene first drew research attention in the late 1990s, when scientists identified the protein it makes (often called LNK) as part of key signaling pathways in blood and immune cells. In recent decades, awareness of this gene’s role has grown as larger genetic studies became possible. Around 2007–2009, early genome-wide studies linked common SH2B3 gene changes to traits such as autoimmune conditions and certain blood and heart related measurements. Over the following years, researchers also reported that rare, more disruptive variants in the SH2B3 gene can be found in some people with specific bone marrow and blood disorders. These findings helped establish SH2B3 as a gene that repeatedly shows up in modern human genetics research.